Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma

Ahmed I.I.K., Sadruddin O., Panarelli J.F.

2023
Eye and Vision

View publication

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

John Moran Eye Center, University of Utah, Salt Lake City, UT, United States; University of Toronto, Toronto, ON, Canada; Prism Eye Institute, Mississauga, ON, Canada; Santen Inc, Emeryville, CA, United States; New York University, New York, NY, United States

Related Publications

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: 2-year Results from a Randomized, Multicenter Study

Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, Grover DS, Khatana AK, Lee B, Nguyen T, Stiles MC, Sadruddin O, Khaw PT.

Omidenepag Isopropyl in Latanoprost Low/Non-Responders with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3, Non-Randomized, Two-Phase, Open-Label Study

Panarelli JF, Bowden EC, Tepedino ME, Odani-Kawabata N, Pei Z, McLaurin EB, Ropo A.

The Development of a SIBS Shunt to Treat Glaucoma

Pinchuk L.

View all Glaucoma publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022